MedPage Today on MSN
Obesity Drops in Adults; Wegovy's Heart Protection; Women Turn to Testosterone
The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
Somehow, it’s becoming even harder to get a GLP-1.
This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...
BMI is a measure of body weight relative to height. The goal for most people is to have a BMI that’s over 18 and under 25.
The 44-year-old comedian — who has shed 'at least 40lbs' with help from GLP-1 weight loss drug Mounjaro — showed off her ...
GlobalData on MSN
GLP-1RA microdosing trend continues despite “anecdotal evidence”
"GLP-1RA microdosing trend continues despite “anecdotal evidence”" was originally created and published by Pharmaceutical ...
Karen McGonigal, 53, died days after she was illegally administered a dose of semaglutide - the powerful ingredient behind Ozempic and Wegovy - in May.
Karen McGonigal's three daughters say she became "desperate" to lose weight after a long-term relationship ended - with ...
Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...
According to the Gallup National Health and Well-Being Index, America’s adult obesity rate has fallen to 37% in 2025, down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results